Related Experiment Videos
Steroid sulfatase inhibitors.
Peter Nussbaumer1, Andreas Billich
1Novartis Institutes for BioMedical Research Vienna, Brunner Strasse 59, A-1235 Vienna, Austria. peter.nussbaumer@pharma.novartis.com
Medicinal Research Reviews
|June 2, 2004
Summary
Steroid sulfatase (STS) inhibitors block local hormone production, offering potential treatments for hormone-dependent conditions like cancer and alopecia. Research highlights both irreversible and reversible inhibitors, with new structural data accelerating drug discovery.
Area of Science:
- Medicinal Chemistry
- Endocrinology
- Enzymology
Background:
- Steroid sulfatase (STS) regulates local estrogen and androgen synthesis from inactive precursors.
- STS inhibitors aim to reduce hormone levels, targeting hormone-dependent diseases.
Purpose of the Study:
- To provide a comprehensive review of medicinal chemistry approaches for STS inhibitors.
- To discuss structure-activity relationships and emerging inhibitor classes.
Main Methods:
- Review of current literature on STS inhibitors.
- Analysis of structure-activity relationships for various inhibitor types.
- Discussion of recent advancements, including reversible inhibitors and X-ray crystallography.
Main Results:
- Identification of potent irreversible arylsulfamate-based STS inhibitors.
- Discovery of novel reversible STS inhibitors.
- Highlighting the impact of STS X-ray structure on research.
Conclusions:
- STS inhibitors represent a promising therapeutic strategy for estrogen- and androgen-dependent disorders.
- Medicinal chemistry efforts continue to yield diverse inhibitor classes.
- Structural insights are poised to drive further development of STS-targeted therapies.